Costly New Drug for AIDS Means Some Go Without
Wall Street Journal 2004 January 13; p. A1, A10
Showing items related by title, author, creator and subject.
In Costly Cancer Drug, Hope and a Dilemma: Some Pay Up to $100,000 a Year for Avastin's Arguable Benefits Kolata, Gina; Pollack, Andrew (2008-07-06)
Fuhrmans, Vanessa (2002-04-11)